SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-beta knockout mice. Journal of Immunology 155(6): 3205-3212, 1995
Modeling Sjögren's syndrome with Id3 conditional knockout mice. Immunology Letters 135(1-2): 34-42, 2011
Id3 knockout mice as a new model for sjogren's syndrome: only a T cell defect or more?. Immunity 21(4): 457-458, 2004
B-lymphocyte depletion ameliorates Sjögren's syndrome in Id3 knockout mice. Immunology 122(1): 73-79, 2007
Sjögren's syndrome (SjS)-like disease of mice: the importance of B lymphocytes and autoantibodies. Frontiers in Bioscience: a Journal and Virtual Library 12: 1767-1789, 2007
Sjogren's syndrome (SjS)-like disease of mice: the importance of B lymphocytes and autoantibodies. Frontiers in Bioscience 12: 1767-1789, 2007
Sjogren's syndrome and Lymphoproliferation. Zhonghua Nei Ke Za Zhi 26(5): 263-5 317, 1987
Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome. Clinical and Experimental Immunology 148(2): 281-287, 2007
Lymphoproliferation in autoimmunity and Sjögren's syndrome. Current Rheumatology Reports 5(4): 317-323, 2003
Immunosialadenitis (Sjögren's syndrome) and lymphoproliferation. Clinical and Experimental Rheumatology 7(2): 175-180, 1989
B-cell lymphoproliferation in primary Sjögren's syndrome. Clinical and Experimental Rheumatology 14 Suppl. 14: S65-S70, 1996
Sjögren's syndrome, lymphoproliferation, and renal tubular acidosis. Annals of Internal Medicine 74(4): 633-634, 1971
Controversies on rituximab therapy in sjögren syndrome-associated lymphoproliferation. International Journal of Rheumatology 2009: 424935, 2009
The spectrum of benign to malignant lymphoproliferation in Sjögren's syndrome. Clinical and Experimental Immunology 10(2): 199-221, 1972
Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjögren's syndrome. Arthritis and Rheumatism 40(2): 318-331, 1997